Advertisement
Journal Home
Search for

Volume 27, Issue 1, Pages 77-90 (February 2010)


View previous. 15 of 16 View next.

Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including “triple negative carcinomas” of low malignant potential

Maria P. Foschini, MDaCorresponding Author Informationemail address, Thomas Krausz, MD, FRCPathb

Salivary gland-type neoplasms of the breast are uncommon and comprise numerous entities analogous to that more commonly seen in salivary glands. The clinicopathologic spectrum ranges from benign to malignant but there are important differences as compared with those of their salivary counterpart. In the breast, benign adenomyoepithelioma is recognized in addition to malignant one, whereas in the salivary gland a histologically similar tumor is designated as epithelial-myoepithelial carcinoma without a separate benign subgroup. Mammary adenoid cystic carcinoma is a low-grade neoplasm compared with its salivary equivalent. It is also important to appreciate that in contrast to “triple negative” conventional breast carcinomas with aggressive course, most salivary-type malignant breast neoplasms behave in a low-grade manner. Most of these tumors are capable of differentiating along both epithelial and myoepithelial lines, but the amount of each lineage-component varies from case to case, contributing to diagnostic difficulties. Well established examples of this group include pleomorphic adenoma, adenomyoepithelioma, and adenoid cystic carcinoma. Another family of salivary gland-type mammary epithelial neoplasms is devoid of myoepithelial cells. Key examples include mucoepidermoid carcinoma and acinic cell carcinoma. The number of cases of salivary gland-type mammary neoplasms in the published data is constantly increasing but some of the rarest subtypes like polymorphous low-grade adenocarcinoma and oncocytic carcinoma are “struggling” to become clinically relevant entities in line with those occurring more frequently in salivary glands.

a Department of Hematology and Oncology, Section of Anatomic Pathology at Bellaria Hospital, “L. and A. Seragnoli” University of Bologna, Bologna, Italy

b Department of Pathology, University of Chicago, Chicago, Illinois

Corresponding Author InformationAddress reprint requests and correspondence: Maria P. Foschini, MD, Anatomia Patologica, Università di Bologna, Ospedale Bellaria, Via Altura 3, 40139 Bologna, Italy

 This work was partly financed with grants from the University of Bologna (RFO).

PII: S0740-2570(09)00097-5

doi:10.1053/j.semdp.2009.12.007


View previous. 15 of 16 View next.

Advertisement